William Garrett Nichols Candel Therapeutics, Inc. (CADL) insider trading activity

William Garrett Nichols is Chief Medical Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 79,320 shares of CADL, which is worth approximately $533,030. The most recent transaction as insider was on Jan 15, 2025, when has been sold 10,428 shares (Common Stock) at a price of $7.22 per share, resulting in proceeds of $75,290. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.3K

30.71% 3M change

41.3% 12M change

Total Value Held $533,030

William Garrett Nichols Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2025	SELL Open market or private sale	$75,290 $7.22 p/Share	10,428 Reduced 11.62%	79,320 Common Stock
Jan 08 2025	SELL Open market or private sale	$88,767 $8.22 p/Share	10,799 Reduced 10.74%	89,748 Common Stock
Nov 29 2024	SELL Open market or private sale	$63,543 $4.56 p/Share	13,935 Reduced 12.17%	100,547 Common Stock
Jul 17 2024	SELL Open market or private sale	$70,361 $6.47 p/Share	10,875 Reduced 8.68%	114,482 Common Stock
Jul 11 2024	SELL Open market or private sale	$58,320 $5.97 p/Share	9,769 Reduced 7.23%	125,357 Common Stock
Nov 28 2023	SELL Payment of exercise price or tax liability	$10,957 $0.9 p/Share	12,175 Reduced 8.27%	135,126 Common Stock
Nov 26 2023	BUY Grant, award, or other acquisition	-	88,822 Added 37.62%	147,301 Common Stock
Nov 28 2022	BUY Grant, award, or other acquisition	-	58,479 Added 50.0%	58,479 Common Stock

WGN

William Garrett Nichols

Chief Medical Officer

Needham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Value

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Candel Therapeutics, Inc.

Track Activities on CADL

Account